Literature DB >> 12042671

Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese population.

Shuichi Fukuen1, Tsuyoshi Fukuda, Hiromi Maune, Yuka Ikenaga, Isamu Yamamoto, Tadanobu Inaba, Junichi Azuma.   

Abstract

In this study, we established useful and reliable methods for the direct detection of the variants of CYP3A5 gene by polymerase chain reaction (PCR) and DdeI restriction analysis. The frequency of CYP3A5 related SNPs in 200 healthy Japanese male subjects was determined. The homozygous wild-type (*1/*1) frequency was 7.0% (14/200), the heterozygous (*1/*3) frequency was 32.5% (65/200) and the homozygous mutant-type (*3/*3) frequency was 60.5% (121/200). The *6 allele was not detected in any of the Japanese individuals. This result suggests that an estimated 40% of the Japanese express relatively high levels of metabolically active CYP3A5 protein. The proposed detection assays are useful for screening the CYP3A5 related SNPs in pharmacogenetic research.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12042671     DOI: 10.1097/00008571-200206000-00009

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  38 in total

Review 1.  Cytochrome P450 3A and their regulation.

Authors:  Oliver Burk; Leszek Wojnowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-21       Impact factor: 3.000

2.  CYP3A5*3 and *6 single nucleotide polymorphisms in three distinct Asian populations.

Authors:  C Balram; Qingyu Zhou; Yin Bun Cheung; Edmund J D Lee
Journal:  Eur J Clin Pharmacol       Date:  2003-05-17       Impact factor: 2.953

3.  Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel.

Authors:  Jung-Won Suh; Bon-Kwon Koo; Shu-Ying Zhang; Kyung-Woo Park; Joo-Youn Cho; In-Jin Jang; Dong-Soon Lee; Dae-Won Sohn; Myoung-Mook Lee; Hyo-Soo Kim
Journal:  CMAJ       Date:  2006-06-06       Impact factor: 8.262

Review 4.  Significance of the minor cytochrome P450 3A isoforms.

Authors:  Ann K Daly
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

5.  Pharmaceutical and genetic determinants for interindividual differences of tacrolimus bioavailability in renal transplant recipients.

Authors:  Takenori Niioka; Hideaki Kagaya; Masatomo Miura; Kazuyuki Numakura; Mitsuru Saito; Takamitsu Inoue; Tomonori Habuchi; Shigeru Satoh
Journal:  Eur J Clin Pharmacol       Date:  2013-06-04       Impact factor: 2.953

Review 6.  Combinations of chromosome transfer and genome editing for the development of cell/animal models of human disease and humanized animal models.

Authors:  Narumi Uno; Satoshi Abe; Mitsuo Oshimura; Yasuhiro Kazuki
Journal:  J Hum Genet       Date:  2017-11-27       Impact factor: 3.172

7.  Impact of CYP3A5 polymorphism on platelet reactivity at percutaneous coronary intervention and after 9 months of aspirin and clopidogrel therapy in Japanese patients with coronary artery disease.

Authors:  Seiji Hokimoto; Tadasuke Chitose; Michio Mizobe; Tomonori Akasaka; Yuichiro Arima; Koichi Kaikita; Satomi Iwashita; Kazunori Morita; Hiroko Miyazaki; Kentaro Oniki; Kunihiko Matsui; Kazuko Nakagawa; Hisao Ogawa
Journal:  Eur J Clin Pharmacol       Date:  2014-04-26       Impact factor: 2.953

8.  Impact of the CYP3A5 genotype on the distributions of dose-adjusted trough concentrations and incidence of rejection in Japanese renal transplant recipients receiving different tacrolimus formulations.

Authors:  Takenori Niioka; Hideaki Kagaya; Mitsuru Saito; Takamitsu Inoue; Kazuyuki Numakura; Ryohei Yamamoto; Tomonori Habuchi; Shigeru Satoh; Masatomo Miura
Journal:  Clin Exp Nephrol       Date:  2017-03-07       Impact factor: 2.801

9.  MDR1 polymorphisms effect cyclosporine AUC0-4 values in Behçet's disease patients.

Authors:  Yoshihiko Katsuyama; Masao Ota; Nobuhisa Mizuki; Akiko Ito; Eiichi Okada; Shigeaki Ohno; Tamihide Matsunaga; Hirofumi Fukushima; Shigeru Ohmori
Journal:  Clin Ophthalmol       Date:  2007-09

10.  Genetic predictors of interindividual variability in hepatic CYP3A4 expression.

Authors:  Vishal Lamba; John C Panetta; Stephen Strom; Erin G Schuetz
Journal:  J Pharmacol Exp Ther       Date:  2009-11-24       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.